A Phase 3, Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Administered By

Awarded By

Contributors

Start/End

  • July 1, 2016 - July 31, 2018